Disc Medicine Files 8-K

Ticker: IRON · Form: 8-K · Filed: Dec 9, 2024 · CIK: 1816736

Disc Medicine, Inc. 8-K Filing Summary
FieldDetail
CompanyDisc Medicine, Inc. (IRON)
Form Type8-K
Filed DateDec 9, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, company-update

TL;DR

Disc Medicine filed an 8-K on Dec 9 for an event on Dec 8. Details TBD.

AI Summary

Disc Medicine, Inc. filed an 8-K on December 9, 2024, reporting an event that occurred on December 8, 2024. The filing indicates a change in the company's status or operations, though specific details of the event are not provided in the excerpt. The company, previously known as Gemini Therapeutics, Inc. and FS Development Corp., is incorporated in Delaware and headquartered in Watertown, Massachusetts.

Why It Matters

This filing signals a material event for Disc Medicine, Inc., requiring disclosure to investors and the public, though the specific nature of the event is not detailed here.

Risk Assessment

Risk Level: medium — An 8-K filing indicates a significant event, but the lack of specific details in this excerpt makes it difficult to assess the immediate risk.

Key Players & Entities

  • Disc Medicine, Inc. (company) — Registrant
  • Gemini Therapeutics, Inc. (company) — Former company name
  • FS Development Corp. (company) — Former company name
  • December 08, 2024 (date) — Date of earliest event reported
  • December 9, 2024 (date) — Date of report

FAQ

What specific event is Disc Medicine, Inc. reporting in this 8-K filing?

The provided excerpt does not specify the exact event being reported in the 8-K filing, only that it occurred on December 8, 2024.

When was the 8-K report filed with the SEC?

The 8-K report was filed on December 9, 2024.

What is the principal executive office address for Disc Medicine, Inc.?

The address is 321 Arsenal Street, Suite 101, Watertown, Massachusetts, 02472.

What were Disc Medicine, Inc.'s former company names?

Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.

What is the Commission File Number for Disc Medicine, Inc.?

The Commission File Number for Disc Medicine, Inc. is 001-39438.

Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-12-09 08:48:56

Key Financial Figures

  • $0.0001 — ch registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma

Filing Documents

01 Other Events

Item 8.01 Other Events. On December 8, 2024, Disc Medicine, Inc. (the "Company") held a previously-announced conference call and webcast to review the Company's data presented at the 66th American Society of Hematology ("ASH") Annual Meeting and Exposition and the Company's operational plans. A copy of the slide presentation presented during this conference call and webcast is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Disc Medicine, Inc. presentation, dated December 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: December 9, 2024 By: /s/ John Quisel, J.D., Ph.D. Name: Title: John Quisel, J.D., Ph.D. Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.